IL150202A0 - Method and composition for the treatment of pain - Google Patents

Method and composition for the treatment of pain

Info

Publication number: IL150202A0
Authority: IL; Israel
Prior art keywords: pain; treatment; composition
Prior art date: 1999-12-23

Application number

IL15020200A

Other languages

English (en)

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-12-23

Filing date

2000-12-19

Publication date

2002-12-01

2000-12-19 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2002-12-01 Publication of IL150202A0 publication Critical patent/IL150202A0/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/503—Pyridazines; Hydrogenated pyridazines spiro-condensed
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)

IL15020200A 1999-12-23 2000-12-19 Method and composition for the treatment of pain IL150202A0 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US17190699P	1999-12-23	1999-12-23
US23683500P	2000-09-29	2000-09-29
PCT/SE2000/002605 WO2001047523A1 (en)	1999-12-23	2000-12-19	Method and composition for the treatment of pain

Publications (1)

Publication Number	Publication Date
IL150202A0 true IL150202A0 (en)	2002-12-01

Family

ID=26867559

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL15020200A IL150202A0 (en)	1999-12-23	2000-12-19	Method and composition for the treatment of pain

Country Status (23)

Country	Link
US (1)	US20030162783A1 (es)
EP (1)	EP1248621A1 (es)
JP (1)	JP2003518499A (es)
KR (1)	KR20020062983A (es)
CN (1)	CN1434714A (es)
AR (1)	AR027038A1 (es)
AU (1)	AU783499B2 (es)
BG (1)	BG106832A (es)
BR (1)	BR0016646A (es)
CA (1)	CA2394561A1 (es)
CO (1)	CO5271687A1 (es)
EE (1)	EE200200348A (es)
HK (1)	HK1048767A1 (es)
HU (1)	HUP0300043A3 (es)
IL (1)	IL150202A0 (es)
IS (1)	IS6428A (es)
MX (1)	MXPA02006154A (es)
NO (1)	NO20022990L (es)
NZ (1)	NZ519389A (es)
PL (1)	PL355850A1 (es)
RU (1)	RU2238094C2 (es)
SK (1)	SK8802002A3 (es)
WO (1)	WO2001047523A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2002026741A1 (en) *	2000-09-29	2002-04-04	Astrazeneca Ab	1,2,5,10-TETRAHYDROPYRIDAZINO[4,5-b]QUINOLINE-1,10-DIONES AND THEIR USE FOR THE TREATMENT OF PAIN
ES2263661T3 (es) *	2000-09-29	2006-12-16	Astrazeneca Ab	1,2,5,10-tetrahidropiridazino(4,5-b)quinolin-1,10-dionas y su uso para el tratamiento del dolor.
EP1325005A1 (en) *	2000-09-29	2003-07-09	AstraZeneca AB	1,2,5,10-tetrahydropyridazino 4,5-b]quinoline-1,10-diones and their use for the treatment of pain
SE0403172D0 (sv) *	2004-12-23	2004-12-23	Astrazeneca Ab	Manufacturing process

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9420590D0 (en) *	1993-10-22	1994-11-30	Zeneca Ltd	Pyridazino quinoline compounds
US6730675B2 (en) *	1999-12-23	2004-05-04	Astrazeneca Ab	Compounds and methods for the treatment of pain
US20050124622A1 (en) *	1999-12-23	2005-06-09	Brown Dean G.	Compounds and methods for the treatment of pain
WO2001047925A1 (en) *	1999-12-23	2001-07-05	Astrazeneca Ab	Compounds and methods for the treatment of pain

2000
- 2000-12-19 EE EEP200200348A patent/EE200200348A/xx unknown
- 2000-12-19 CA CA002394561A patent/CA2394561A1/en not_active Abandoned
- 2000-12-19 WO PCT/SE2000/002605 patent/WO2001047523A1/en not_active Ceased
- 2000-12-19 HK HK03100969.4A patent/HK1048767A1/zh unknown
- 2000-12-19 JP JP2001548117A patent/JP2003518499A/ja active Pending
- 2000-12-19 US US10/168,745 patent/US20030162783A1/en not_active Abandoned
- 2000-12-19 NZ NZ519389A patent/NZ519389A/en unknown
- 2000-12-19 KR KR1020027008040A patent/KR20020062983A/ko not_active Ceased
- 2000-12-19 EP EP00989115A patent/EP1248621A1/en not_active Withdrawn
- 2000-12-19 RU RU2002115273/14A patent/RU2238094C2/ru not_active IP Right Cessation
- 2000-12-19 MX MXPA02006154A patent/MXPA02006154A/es active IP Right Grant
- 2000-12-19 SK SK880-2002A patent/SK8802002A3/sk not_active Application Discontinuation
- 2000-12-19 AU AU25660/01A patent/AU783499B2/en not_active Ceased
- 2000-12-19 BR BR0016646-4A patent/BR0016646A/pt not_active IP Right Cessation
- 2000-12-19 IL IL15020200A patent/IL150202A0/xx unknown
- 2000-12-19 PL PL00355850A patent/PL355850A1/xx not_active Application Discontinuation
- 2000-12-19 HU HU0300043A patent/HUP0300043A3/hu unknown
- 2000-12-19 CN CN00819119A patent/CN1434714A/zh active Pending
- 2000-12-20 AR ARP000106798A patent/AR027038A1/es not_active Application Discontinuation
- 2000-12-21 CO CO00097101A patent/CO5271687A1/es not_active Application Discontinuation
2002
- 2002-06-18 BG BG106832A patent/BG106832A/bg unknown
- 2002-06-19 IS IS6428A patent/IS6428A/is unknown
- 2002-06-20 NO NO20022990A patent/NO20022990L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
HK1048767A1 (zh)	2003-04-17
NZ519389A (en)	2004-05-28
EE200200348A (et)	2003-08-15
JP2003518499A (ja)	2003-06-10
EP1248621A1 (en)	2002-10-16
NO20022990D0 (no)	2002-06-20
KR20020062983A (ko)	2002-07-31
CN1434714A (zh)	2003-08-06
US20030162783A1 (en)	2003-08-28
NO20022990L (no)	2002-08-20
WO2001047523A1 (en)	2001-07-05
AR027038A1 (es)	2003-03-12
HUP0300043A2 (en)	2003-05-28
PL355850A1 (en)	2004-05-31
MXPA02006154A (es)	2002-12-05
RU2238094C2 (ru)	2004-10-20
BG106832A (bg)	2003-03-31
HUP0300043A3 (en)	2007-05-02
AU2566001A (en)	2001-07-09
CO5271687A1 (es)	2003-04-30
BR0016646A (pt)	2002-10-08
IS6428A (is)	2002-06-19
AU783499B2 (en)	2005-11-03
CA2394561A1 (en)	2001-07-05
SK8802002A3 (en)	2003-06-03

Publication	Publication Date	Title
PT1231887E (pt)	2013-02-21	Método e composição para o tratamento de cicatrizes
HUP0103621A3 (en)	2005-05-30	Fentanyl composition for the treatment of acute pain
EP1200086A4 (en)	2009-05-27	THERAPEUTIC OR PROPHYLACTIC METHODS OF PAIN AND ANXIETY
GB9824436D0 (en)	1999-01-06	Methods of treatment
HU0001471D0 (en)	2000-06-28	New method of treatment
KR100510795B1 (en)	2005-08-30	Compositions and Methods for the Treatment of Tumor
AU3784999A (en)	1999-11-23	Methods for treatment of pain
HUP0200738A3 (en)	2003-03-28	Method of the treatment of incontinence
IL141426A0 (en)	2002-03-10	Compositions and methods for the treatment of tumor
IL143212A0 (en)	2002-04-21	Compositions and methods for the treatment of tumor
AU2420101A (en)	2001-07-09	Method and composition for the treatment of pain
AU2566201A (en)	2001-07-09	Compounds and methods for the treatment of pain
HUP0300043A3 (en)	2007-05-02	Method and composition for the treatment of pain
GB9906808D0 (en)	1999-05-19	Formulation for treatment of pain
GB9904252D0 (en)	1999-04-21	Composition for the treatment of pain
IL150208A0 (en)	2002-12-01	Compound and method for the treatment of pain
HUP0200005A3 (en)	2003-03-28	Composition for the treatment of psoriasis and process for its preparation
AU5169200A (en)	2001-01-02	Methods and compositions for treating breakthrough pain
AU2420201A (en)	2001-07-09	Compounds and methods for the treatment of pain
EP1087766A4 (en)	2001-11-21	TREATMENT METHOD
KR100511819B1 (en)	2005-09-02	Compositions and Methods for the Treatment of Tumor
GB0021287D0 (en)	2000-10-18	Composition and method for the treatment of cancers
HK1045651A (en)	2002-12-06	Methods for treating or preventing pain and anxiety
GB9930342D0 (en)	2000-02-09	Improved composition and method for the treatment of drug abuse
GB9926218D0 (en)	2000-01-12	Composition and method for the treatment of drug abuse